OTCMKTS:GALNF Galenica (GALNF) Stock Forecast, Price & News C$75.25 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share Today's RangeC$75.25▼C$75.2550-Day RangeC$75.25▼C$75.2552-Week RangeC$75.25▼C$75.25VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Galenica (OTCMKTS:GALNF) StockGalenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.Read More Receive GALNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galenica and its competitors with MarketBeat's FREE daily newsletter. Email Address GALNF Stock News HeadlinesMay 20, 2023 | americanbankingnews.comGalenica (OTCMKTS:GALNF) Raised to Hold at Deutsche Bank AktiengesellschaftSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GALNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galenica and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Distribution Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GALNF CUSIPN/A CIKN/A Webwww.galenica.com Phone41 58 852 81 11FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Marc Werner (Age 56)Chief Exec. Officer Comp: $1.34MMr. Felix Burkhard (Age 57)CFO & Head of Investor Relations Ms. Barbara WalchliGen. Counsel & Gen. Sec.Ms. Christina HertigHead of Corp. CommunicationsDr. Thomas F. Szuran (Age 56)Chief Products & Marketing Officer Ms. Marianne Ellenberger (Age 60)Head of HR Dr. Jörg Kneubühler (Age 63)Advisor Mr. Daniele Madonna (Age 46)Chief Healthcare Officer Mr. Andreas Koch (Age 52)Head of Wholesale & Logistics Ms. Virginie Pache Jeschka (Age 44)Chief Pharmacies Officer More ExecutivesKey CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFMcKesson EuropeOTCMKTS:CAKFYMediosOTCMKTS:MEDOFShanghai PharmaceuticalsOTCMKTS:SHPMFView All Competitors GALNF Stock - Frequently Asked Questions Should I buy or sell Galenica stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Galenica in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GALNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GALNF, but not buy additional shares or sell existing shares. View GALNF analyst ratings or view top-rated stocks. How have GALNF shares performed in 2023? Galenica's stock was trading at C$75.25 at the beginning of 2023. Since then, GALNF stock has increased by 0.0% and is now trading at C$75.25. View the best growth stocks for 2023 here. What is Galenica's stock symbol? Galenica trades on the OTCMKTS under the ticker symbol "GALNF." How do I buy shares of Galenica? Shares of GALNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Galenica's stock price today? One share of GALNF stock can currently be purchased for approximately C$75.25. How can I contact Galenica? The official website for the company is www.galenica.com. The company can be reached via phone at 41 58 852 81 11. This page (OTCMKTS:GALNF) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galenica AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.